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1. Introduction 
The control of the enzymic oxidation of phenols 
has practical significance in the therapy of melanomas 
[l] and leprosy [2], in senescence [3] and food 
processing [4]. Extracts inhibitory to mushroom 
tyrosinase have been obtained from mushrooms [5,6], 
from guinea pig skin [7,8], from the fungus Ductylium 
dendriodes [9] and from potato tubers [lo] . The 
inhibitors in these extracts have all been described as 
proteins. Many of their properties however, are dissim- 
ilar indicating different entities even from the same 
sources [7]. 
Tyrosinase (EC 1.10.3.1) is widely distributed in 
plants and animals and its activity on phenolic sub- 
strates becomes particularly apparent in injured tissues 
of apple, banana and potato. 
This paper describes the properties of a tyrosinase 
inhibitor purified by column and affinity chromato- 
graphy. 
2. Materials and methods 
2. I Organism 
The mushroom Agaricus hortensis Cke. was obtained 
commercially and identified by the late Dr J. Walton 
Groves, mycologist, Canada Department of Agriculture. 
2.2 Extraction of the inhibitor 
The inhibitors were extracted from the frozen and 
1.56 
thawed sporophores by homogenizing in pyridine-acet- 
ate buffer (0.5 M, pH 7.2). 
2.3 Putification by affinity chromatography 
The active freeze-dried fraction (20.5 mg) obtained 
by chromatography on a Sephadex G25 column was 
adsorbed in bulk onto phloroglucinol-hydroxylated 
agarose [ 1 l] coupled with tyrosinase by the cyanogen 
bromide method [ 121 for 3 hr at 22°C in pyridine- 
acetate buffer (0.02 M, pH 7.2). The inhibitors were 
desorbed from the coupled and adsorbed agarose 
column (1.4 X 2.8 cm) with pyridine-acetate buffers 
0.02 M, pH 8.2 and 0.2 M, pH 5 respectively. 
2.4 Electrophoresis 
Electrophoresis on 7% acrylamide gel followed the 
method described by Davis [ 131. Immuno-electro- 
phoresis was performed on microslides (L.K.B. Produk- 
ter, AB Stockholm) using antiserum developed against 
A. hortensis [5] . 
2.5 Ultraviolet radiation 
A water solution of the inhibitor (1 mg/ml) 1 ml 
deep in an open container, was irradiated at 336 E.tm 
for 1 hr. The light source (Ultra-Violet Products Inc., 
California) was 10 cm from the solution. 
2.6 Assay for the inhibitor 
One ml of mushroom tyrosinase (Nutritional Bio- 
chemical Corporation) producing a change in 10 units 
OD/minute at 475 nm with dopa (3,4-dihydroxy- 
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phenylalanine) as substrate, and one ml inhibitor sample 
were incubated for 3 hr at 22°C before reacting with 
1 ml of dopa (0.1 M). Controls, omitting the inhibitor, 
were treated similarly. 
2.7 Assay for sulfhvdryl groups 
Sulthydryl groups were determined by the method 
of Sedlak and Lindsay [ 141. 
3, Results 
Two inhibitors (Ia, Ib) were desorbed with pyridine- 
acetate buffers 0.02 M, pH 8.2 and 0.2 M, pH 5 
4 64nm 
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Fig. 1. Desorption of tyrosinase inhibitors (Ia, Ib) from 
phloroglucinol-hydroxylated-tyrosinase coupled agarose 
column (1.4 X 2.8 cm). The inhibitors were adsorbed from 
20.5 mg, active Sephadex G25 column fraction for 3 hr at 
22°C in pyridine-acetate buffer (0.02 M, pH 7.2). Desorption 
buffers were pyridine-acetate, O.O2M, pH 8.2 (X) and 0.2 M 
pH 5 (y). Desorbed la, Ib were 4.4 mg and 12.8 mg 
respectively. Rate: 20 ml/hr, fractions 5 ml. 
Fig. 2. Absorption spectra of tyrosinase inhibitors (Ia, Ib) 
separated by affinity chromatography. 
respectively (fig. 1). Ia had an absorption maximum 
at 254 pm (fig. 2) and reacted positively with nin- 
hydrin. Acrylamide gel disc and immunoelectrophoresis 
disclosed one protein band (fig. 3). Amino acid 
analysis of the acid hydrolysate of Ia (6N HCI for 
12 hr at 110°C) produced three major amino acids, 
phenylalanine, aspartic and glutamic acids in the 
approximate ratio 1: 1: 1 (table 1). The molecular 
Fig. 3. Electrophoresis [131 of tyrosinase inhibitor (Ia) on 
7% acrylamide gel (A) and immuno-electrophoresis [5] of 
tyrosinase inhibitor (Ia). Antiserum was developed against 
A. hortensis extract. 
Table 1 
Amino acid analysis of peptide inhibitor of tyrosinase 
obtained from the mushroom A. hortensis 
Amino acid CtM/mg 
Histidine 
Asparagine 
Threonine 
Serine 
Glutamic acid 
Glycine 
Alanine 
Phenylalanine 
Ammonia 
.037 
.665 
.052 
.020 
.574 
.022 
.185 
.710 
34.16 
157 
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weight of Ia, based on amino acid analyses and 
Sephadex Cl 5 chromatography, was estimated at 
1200. The inhibitor was relatively insoluble in 
organic solvents, was freely soluble in water and does 
not contain sulfhydryl groups. The inhibitory capacity 
was not affected by ultraviolet radiation. Ia demonstrat- 
ed competitive inhibition (fig. 4) with dopa substrate. 
The inhibitor Ib, desorbed at pH 5, displayed 
maximum absorption at 230 pm with a shoulder at 
254 I.tm. The desorption pattern (fig. 1) suggest a 
heterogenous eluate which inhibited tyrosinase non- 
competitively (fig. 4). 
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Fig. 4. Lineweaver-Burk plots showing inhibition of tyrosinase 
catalysis of dopa oxidation by mushroom inhibitors la and Ib. 
4. Discussion 
The inhibitor (Ia) of tyrosinase isolated in these 
experiments shows some similarity to that described 
by Flawn and Wilde [7,8] in its W stability, low 
molecular weight peptide nature and its apparent 
sensitivity to ammonium acetate buffers. The inhibitor 
was not affected by pyridine-acetate buffers and 
maintained its activity throughout these experiments. 
The competitive inhibition by Ia described here was 
also demonstrated with other tyrosinase inhibitors 
[l&16]. 
The phenylahmine content of the peptide 
undoubtedly accounts for the absorption maximum 
at 254 pm. The inhibitor eluate (Ib) desorbed at pH 5, 
with a secondary absorption shoulder at 254 Mm. 
possibly contains some Ia but the major component 
absorbs at 230 I.tm. 
Incubation of the inhibitor (Ia) with the enzyme for 
a minimum of 2.5 hr was necessary for optimum 
activity suggesting possible conformational changes of 
the enzyme molecule. This phenomenon, also described 
by Hare1 et al. [9], is being investigated currently. 
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